Latest research, clinical studies, and emerging treatments.
Minoxidil works by opening potassium channels. Understanding this mechanism helps interpret density data and explains why some users respond better than others.
Rapamycin inhibits mTOR and shows anti-aging effects including potential hair cycle extension. myhairline.ai will track density response to topical rapamycin as clinical trials progress.
Your tracking data can contribute to hair loss research. Learn how the myhairline.ai research program uses anonymized data to improve hair loss science.
The scalp microbiome influences follicle health and androgenetic alopecia progression. Track density changes alongside probiotic and scalp microbiome interventions with myhairline.ai.
Senolytic drugs clear senescent cells from tissues. Research suggests targeting follicular senescence may restore hair density in aging patients.
The Sonic Hedgehog pathway controls hair follicle cycling. Understanding this pathway helps interpret why certain treatment combinations produce synergistic density responses.
15-PGDH inhibitors like SW033291 boost local PGE2 and have shown dramatic hair regrowth in animal studies. Track these treatments as they enter human trials.
Telomere shortening in hair follicle stem cells is linked to androgenetic alopecia progression. Learn how tracking data reveals your follicle aging rate.
Thymosin Beta-4 (TB500) activates hair follicle stem cells through wound-healing pathways. Track density response to TB500 protocols with objective data.
Combine TrichoScan clinical sessions with myhairline.ai home tracking for complete density monitoring. Learn the optimal protocol for both systems.
Learn how trichoscopy dermoscopic findings like peripilar sign and yellow dots connect to AI density tracking metrics. Bridge clinical and home data.
The vellus-to-terminal hair ratio is a diagnostic marker for androgenetic alopecia. Track this ratio with AI photo analysis for a quantitative AGA severity score.